WORK Medical Technology Group LTD Ordinary Shares (WOK) Competitors $1.07 -0.27 (-20.15%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.07 0.00 (-0.37%) As of 02/21/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrends WOK vs. STIM, ECOR, PDEX, TELA, FONR, SRTS, MGRM, ICAD, MLSS, and EDAPShould you be buying WORK Medical Technology Group LTD Ordinary Shares stock or one of its competitors? The main competitors of WORK Medical Technology Group LTD Ordinary Shares include Neuronetics (STIM), electroCore (ECOR), Pro-Dex (PDEX), TELA Bio (TELA), FONAR (FONR), Sensus Healthcare (SRTS), Monogram Orthopaedics (MGRM), iCAD (ICAD), Milestone Scientific (MLSS), and Edap Tms (EDAP). These companies are all part of the "medical equipment" industry. WORK Medical Technology Group LTD Ordinary Shares vs. Neuronetics electroCore Pro-Dex TELA Bio FONAR Sensus Healthcare Monogram Orthopaedics iCAD Milestone Scientific Edap Tms WORK Medical Technology Group LTD Ordinary Shares (NASDAQ:WOK) and Neuronetics (NASDAQ:STIM) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, community ranking, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends. Does the MarketBeat Community favor WOK or STIM? Neuronetics received 128 more outperform votes than WORK Medical Technology Group LTD Ordinary Shares when rated by MarketBeat users. CompanyUnderperformOutperformWORK Medical Technology Group LTD Ordinary SharesN/AN/ANeuroneticsOutperform Votes12868.45% Underperform Votes5931.55% Do analysts rate WOK or STIM? Neuronetics has a consensus target price of $4.67, indicating a potential upside of 12.99%. Given Neuronetics' stronger consensus rating and higher possible upside, analysts clearly believe Neuronetics is more favorable than WORK Medical Technology Group LTD Ordinary Shares.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score WORK Medical Technology Group LTD Ordinary Shares 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Neuronetics 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has higher earnings and valuation, WOK or STIM? WORK Medical Technology Group LTD Ordinary Shares has higher earnings, but lower revenue than Neuronetics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWORK Medical Technology Group LTD Ordinary Shares$11.51M1.36N/AN/AN/ANeuronetics$71.35M1.76-$30.19M-$1.23-3.36 Is WOK or STIM more profitable? WORK Medical Technology Group LTD Ordinary Shares has a net margin of 0.00% compared to Neuronetics' net margin of -50.09%. WORK Medical Technology Group LTD Ordinary Shares' return on equity of 0.00% beat Neuronetics' return on equity.Company Net Margins Return on Equity Return on Assets WORK Medical Technology Group LTD Ordinary SharesN/A N/A N/A Neuronetics -50.09%-141.24%-32.77% Do insiders and institutionals have more ownership in WOK or STIM? 53.6% of Neuronetics shares are held by institutional investors. 9.8% of Neuronetics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media favor WOK or STIM? In the previous week, Neuronetics had 7 more articles in the media than WORK Medical Technology Group LTD Ordinary Shares. MarketBeat recorded 7 mentions for Neuronetics and 0 mentions for WORK Medical Technology Group LTD Ordinary Shares. Neuronetics' average media sentiment score of 0.53 beat WORK Medical Technology Group LTD Ordinary Shares' score of 0.00 indicating that Neuronetics is being referred to more favorably in the news media. Company Overall Sentiment WORK Medical Technology Group LTD Ordinary Shares Neutral Neuronetics Positive SummaryNeuronetics beats WORK Medical Technology Group LTD Ordinary Shares on 10 of the 13 factors compared between the two stocks. Get WORK Medical Technology Group LTD Ordinary Shares News Delivered to You Automatically Sign up to receive the latest news and ratings for WOK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WOK vs. The Competition Export to ExcelMetricWORK Medical Technology Group LTD Ordinary SharesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.55M$4.59B$5.77B$8.99BDividend YieldN/A39.91%4.78%3.85%P/E RatioN/A31.4526.4618.82Price / Sales1.3650.23453.6978.73Price / CashN/A51.2344.0437.47Price / BookN/A6.577.634.64Net IncomeN/A$90.13M$3.18B$245.69M7 Day Performance-53.07%-2.20%-1.91%-2.66%1 Month Performance-79.46%-2.17%-0.19%-2.15%1 Year PerformanceN/A15.26%16.70%12.90% WORK Medical Technology Group LTD Ordinary Shares Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WOKWORK Medical Technology Group LTD Ordinary SharesN/A$1.07-20.1%N/AN/A$19.55M$11.51M0.00226Lockup ExpirationGap DownSTIMNeuronetics1.6444 of 5 stars$3.86+25.7%$4.67+20.9%+29.3%$117.15M$71.35M-3.14180High Trading VolumeECORelectroCore2.504 of 5 stars$17.04+2.7%$25.00+46.7%+151.4%$113.49M$16.03M-9.3150PDEXPro-Dex3.7438 of 5 stars$33.25-1.0%$52.00+56.4%+81.8%$108.43M$61.00M16.54140TELATELA Bio2.8073 of 5 stars$2.67flat$9.25+246.4%-61.1%$105.17M$58.45M-1.58120Positive NewsFONRFONAR2.2093 of 5 stars$16.01+2.6%N/A-35.7%$101.34M$102.88M11.44480Earnings ReportNews CoverageSRTSSensus Healthcare1.9855 of 5 stars$6.07+3.9%$14.67+141.6%+15.2%$99.49M$41.81M15.1840High Trading VolumeMGRMMonogram Orthopaedics3.7979 of 5 stars$2.82+1.1%$4.00+41.8%-24.9%$96.75M$370,000.00-6.0028News CoverageICADiCAD0.5813 of 5 stars$3.60+10.1%N/A+92.9%$95.54M$17.32M-27.69140Analyst UpgradeNews CoverageGap UpMLSSMilestone Scientific0.8096 of 5 stars$1.21-2.4%$1.25+3.3%+57.3%$94.25M$9.83M-17.2830News CoverageEDAPEdap Tms2.8598 of 5 stars$2.53+1.0%$19.00+652.5%-57.2%$93.68M$65.42M-3.88230 Related Companies and Tools Related Companies Neuronetics Alternatives electroCore Alternatives Pro-Dex Alternatives TELA Bio Alternatives FONAR Alternatives Sensus Healthcare Alternatives Monogram Orthopaedics Alternatives iCAD Alternatives Milestone Scientific Alternatives Edap Tms Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:WOK) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WORK Medical Technology Group LTD Ordinary Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share WORK Medical Technology Group LTD Ordinary Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
